Clinical Trials in France — Country Dashboard | 4,496 EU Studies

Filter these 4,496 trials by condition, phase, sponsor and more.

Open in Search →

4,496 Registered trials

1,845 Recruiting

2,146 Completed trials

904 Sponsors active

1,193 Research sites

Phase III

Phase II

Phase III: 1870 Phase II/III: 208 Phase II: 1262 Phase I/II: 286 Phase III/IV: 51 Phase IV: 173 Phase I: 239 Phase I (Other): 177 Phase I (FiH): 217 Other: 8 Other: 5

Oversight events in trials active here:

104 serious breaches 876 temporary halts 92 urgent safety measures 105 unexpected events 179 corrective measures across 541 trials

View oversight register →

Top conditions

Non-small cell lung cancer 154 Non-small cell lung cancer metastatic 52 Colorectal cancer 39 Ovarian cancer 37 Squamous cell carcinoma of head and neck 32 Systemic lupus erythematosus 30 Endometrial cancer 28 Breast cancer 28 Non-small cell lung cancer stage IV 27 Myelodysplastic syndrome 27 Diffuse large B-cell lymphoma 26 Triple negative breast cancer 26

Top sponsors

Assistance Publique Hopitaux De Paris 264 Centre Hospitalier Universitaire De Nantes 195 Merck Sharp & Dohme LLC 177 Novartis Pharma AG 165 F. Hoffmann-La Roche AG 144 AstraZeneca AB 143 Janssen - Cilag International 115 AbbVie Deutschland GmbH & Co. KG 97 Sanofi-Aventis Recherche & Developpement 72 Glaxosmithkline Research & Development Limited 66 Bristol-Myers Squibb Services Unlimited Company 65 Unicancer 65

Cities with most trials

All 448 cities →

All trials — page 4

4,496 total

SYMBOL CLINICAL : Treatment of severe ocular chemical burns by subconjunctival injection of allogeneic mesenchymal stem cells: a multicentre… Pending

2023-509713-37-00 Phase II Patient with severe eye chemical burns Hopital Fondation Adolphe De Rothschild
Nebulized Amikacine for Ventilator associated gram negative Pneumonia in ECMO veno-arterial patients: A randomized Pilot Study (NAVAP-ECMO) Pending

2023-509722-22-00 Phase II gram-negative bacillus pneumonia acquired during mechanical … Assistance Publique Hopitaux De Paris
A First In Human Phase I Trial Evaluating safety, tolErability and ResponSe of [211At]At-Girentuximab (ATO-101™) in PatiEnts with Non-Muscle… Pending

2023-509729-33-00 Phase I Non-Muscle-Invasive Bladder Cancer (NMIBC) refractory Institut De Cancerologie De L Ouest
Evaluation of a therapeutic de-eScalation strategy based on therapeutic drug MOnitOring in chronic non-infectious uveitis Treated witH adali… Pending

2023-509733-39-00 Phase IV noninfectious uveitis Centre Hospitalier Universitaire De Saint Etienne
E. coli Urinary Tract Infection Study Pending

2023-509777-23-00 Phase I Bacterial urinary infection Phagenix
TicAgreLor versus placebo to prevent cerebral ISCHemia in anEuRysmal low grade SAH A double blinded randomised controlled study Pending

2023-509795-42-00 Phase III Aneurysmal subarachnoid hemorrhage Centre Hospitalier Universitaire De Toulouse
Efficacy and Safety of Cryotherapy followed by Tirbanibulin ointment for actinic keratosis on the scalp and forehead Pending

2023-509931-15-00 Phase III/IV Patients (male or female) ≥18 years old with scalp and foreh… Centre Hospitalier Universitaire De Lille
A multicentre, double-blind, randomized controlled trial of inhaled amikacin versus placebo in critically ill patients with ventilator-assoc… Pending

2023-510075-63-00 Phase III Patients with ventilator-associated tracheobronchitis Centre Hospitalier Regional Universitaire De Tours
Exploratory Pragmatic trial of fosfomycin-trometamol treatment of male urinary tract infections in primary care. Pending

2023-510355-36-00 Phase III Male Urinary Tract Infection CHU De Rouen
Corticoid Therapy in Acute Myocarditis Pending

2024-510602-90-00 Phase III Patients presenting with acute myocarditis proven by cardiac… Assistance Publique Hopitaux De Paris
Aspirin in acute pneumonia in the elderly: a multicenter, double-blind, randomized, placebo-controlled trial Pending

2024-510811-32-00 Phase III acute pneumonia Centre Hospitalier Universitaire De Dijon
Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed Pending

2024-511054-50-00 Phase II/III HIV-1 Infection Gilead Sciences Inc.
SEMAFORCRANIO : Multicenter, double-blind, parallel, randomized controlled trial of the efficacy of semaglutide in hypothalamic obesity seco… Pending

2024-511114-20-00 Phase III Craniopharyngioma Centre Hospitalier Universitaire D'Angers
Sarilumab efficacy and safety in adults with early polymyalgia rheumatica Pending

2024-511296-15-00 Phase III Musculoskeletal diseases Sanofi-Aventis Recherche & Developpement
PNOC029_Tovorafenib for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults Pending

2024-511510-20-00 Phase II craniopharyngioma Prinses Maxima Centrum voor Kinderoncologie B.V.
ESP-BACK : Erector Spinae Plane Block for acute low back pain Pending

2024-511595-32-00 Phase IV Acute low back pain Centre Hospitalier Universitaire De Montpellier
APICALE - Cervical facet injection of corticosteroids for the management of cervicobrachialgia : protocol for a randomized pilot study Pending

2024-511790-30-00 Phase III Cervicobrachial Neuralgia Assistance Publique Hopitaux De Paris
TIC-TAC-SAM « Comparison of two strategies of etoposide initiation in severe sporadic hemophagocytic lymphohistiocytosis in intensive care: … Pending

2024-511807-41-01 Phase III Hemophagocytic lymphohistiocytosis (HLH) Assistance Publique Hopitaux De Paris
A first-in-human, open-label, clinical study to assess the safety, tolerability, and activity of OT-C001 (amplified/activated allogenic natu… Pending

2024-511843-24-00 Phase I Relapsed/refractory (R/R) diffuse large B-cell lymphoma Emercell SAS
Efficacy of certolizumab in women with unexplained recurrent implantation failure: a double-blind randomized controlled trial (CERTIFY) Pending

2024-511869-11-00 Phase III Adult women with recurrent implantation failures (RIF) Assistance Publique Hopitaux De Paris
Multisite open-label randomized phase II clinical trial in newly diagnosed glioblastoma treated by concurrent TemoRadiation and adjuvant tem… Pending

2024-511880-27-00 Phase II Newly diagnosed Glioblastoma (IDH wild-type) patients at ini… Assistance Publique Hopitaux De Paris
Safety study for the use of Rapamycin in children with familial adenomatous polyposis - RAPA-4-FAP Pending

2024-512079-11-00 Phase II Familial adenomatous polyposis Centre Hospitalier Universitaire De Toulouse
New therapeutic approach to Toxic Epidermal Necrolysis (TEN) using anti-CD38+ antibodies in the active phase of the disease – Phase I/II stu… Pending

2024-512164-63-00 Phase I/II Toxic Epidermal Necrolysis Hospices Civils De Lyon
A trial to learn how well Dato-DXd and rilvegostomig work and how safe they are in participants with stage I adenocarcinoma non-small cell l… Pending

2024-512195-35-00 Phase III Stage I adenocarcinoma non-small cell lung cancer (NSCLC) wi… AstraZeneca AB

Showing 73–96 of 4,496 trials

← All countries